Author: UBRIGENE BIOSCIENCES INC

Posted Date:

March 30, 2026

uBriGene and Cellinfinity BIO Announce Strategic Partnership to Advance In Vivo CAR-T Therapies

UBRIGENE BIOSCIENCES INC

March 30, 2026
uBriGene Congratulates Strategic Partner Grit Biotechnologies on FDA IND Clearance for Its Next-Generation GT307 TIL Therapy

UBRIGENE BIOSCIENCES INC

March 16, 2026